januvia glp 1 Sitagliptin/Metformin (Janumet) as Combination Therapy In the Treatment of Type-2 Diabetes Mellitus Januvia - Treatment of Diabetes

Ballarini, T

On average, people achieved weight loss ranging from around 5% to more than 10% of their initial body weight over the course of the trials, which generally lasted around six months to a year

Health economic benefits are essential if the manufacturers are going to make oral obesity drugs popular on the market

To optimize model performance, we used tenfold cross-validation to select the optimal hyperparameter ( k ) from a range of values ( k = 5, 10, 15, 20)

The FDAs approval of resmetirom changes the MASH drug development landscape for the better after years of failed programs 3

Gu J, Liu S, Mu N, Huang T, Zhang W, Zhao H, Shu Z, Zhang C, Hao Q, Li W, Xue X, Zhang W, Zhang Y (2017) A DPP-IV-resistant glucagon-like peptide-2 dimer with enhanced activity against radiation-induced intestinal injury